APA (7th ed.) Citation

Sussman, M., Benner, J., Mugwagwa, T., Lee, J., Hung, S., Yang, Y., & Chen, Y. Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach. MDPI AG.

Chicago Style (17th ed.) Citation

Sussman, Matthew, Jennifer Benner, Tendai Mugwagwa, Jackie Lee, Sheng-Tzu Hung, Ya-Min Yang, and Yixi Chen. Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach. MDPI AG.

MLA (9th ed.) Citation

Sussman, Matthew, et al. Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach. MDPI AG.